<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05084443</url>
  </required_header>
  <id_info>
    <org_study_id>CS11102</org_study_id>
    <nct_id>NCT05084443</nct_id>
  </id_info>
  <brief_title>Effect of Roselle-based Drink on Blood Pressure and Skin</brief_title>
  <official_title>Effect of Roselle-based Drink on Blood Pressure, Antioxidative Activity and Skin Condition</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chung Shan Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chung Shan Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized, placebo-controlled, double-blind, and cross-over study was designed to check&#xD;
      whether the roselle-based drink (2 bottles every day) can alter blood pressure and skin&#xD;
      condition in elderly healthy subjects.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The subjects were assigned into two groups (control group and test group), each group subject&#xD;
      was requested to drink 2 bottles every day (100 mL/bottle, one in the morning and another in&#xD;
      the evening), the rate of drinking is 75.42%. There are 39 subjects (25 females and 14 males)&#xD;
      completely involved in the thirteen-month trial (cross-over). Blood samples were collected at&#xD;
      the initial, 3rd, 6th, 7th, 10th, 13th months of the trial. Skin examinations were performed&#xD;
      at the initial, 6th, 7th, 13th months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 11, 2017</start_date>
  <completion_date type="Actual">October 19, 2018</completion_date>
  <primary_completion_date type="Actual">June 15, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood pressure by sphygmomanometer (mmHg)</measure>
    <time_frame>6 months</time_frame>
    <description>Both systolic and diastolic blood pressure were changed after Roselle drink</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">52</enrollment>
  <condition>Other Skin and Subcutaneous Infections</condition>
  <arm_group>
    <arm_group_label>Placebo/Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo drink-- Orally (200 ml/day)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Roselle Based drink (Test)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Roselle-Based Drink--- Orally (200 ml/day)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Drink</intervention_name>
    <description>Roselle and placebo drink for 6 months</description>
    <arm_group_label>Placebo/Control</arm_group_label>
    <arm_group_label>Roselle Based drink (Test)</arm_group_label>
    <other_name>Roselle Drink (SF-R product of Han Bu)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy adults&#xD;
&#xD;
          -  Subjects should not be under any medication&#xD;
&#xD;
          -  Subject must be able to drink&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subjects with chronic renal, liver or cardiac disorders, Diabetes, hyperlipidemia.&#xD;
&#xD;
          -  Also pregnant women, chain smokers, high alcohol consumers should not be included.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>81 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chin-Kun Wang, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chung Shan Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Chung Shan Medical University</name>
      <address>
        <city>Taichung city</city>
        <state>Taichung</state>
        <zip>40201</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 29, 2021</study_first_submitted>
  <study_first_submitted_qc>October 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2021</study_first_posted>
  <last_update_submitted>October 19, 2021</last_update_submitted>
  <last_update_submitted_qc>October 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chung Shan Medical University</investigator_affiliation>
    <investigator_full_name>Chin Kun Wang</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

